Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)

Abroad (travel likely)RecruitingPHASE2

Conditions

Small-cell Lung Cancer · Extensive-stage Small-cell Lung Cancer · Lung Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Chicago Medicine, Chicago, Illinois, United States
Contact: Study coordinator (Clinical Trials Intake) · cancerclinicaltrials@bsd.uchicago.edu · 855-702-8222
University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, United States

Study leads

Christine Bestvina, MD
Principal Investigator
University of Chicago - Comprehensive Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

Cancer · Tumor, Solid · Malignant Neoplasm

Abroad (travel likely)RecruitingPHASE1, PHASE2

Austin, United States · Irving, United States

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Solid Tumor, Adult · Colorectal Cancer · Non Small Cell Lung Cancer

Abroad (travel likely)Recruiting

Gilbert, United States · Phoenix, United States

7T Brain MRI Scan for Micro-brain Metastasis (microBM) Detection for Patients With Small-cell Lung Cancer (SCLC), Who Decline Prophylactic Cranial Irradiation (PCI)

Small-cell Lung Cancer · Brain Metastases

Abroad (travel likely)Recruiting

Columbia, United States

Efficacy and Safety of Super-hyperfractionation Pulse Radiotherapy Combined With ICIs for Advanced NSCLC

Lung Cancer · Immune Checkpoint Inhibitor · Radiotherapy

Abroad (travel likely)Recruiting

Chongqing, China · Chongqing, China